{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:14:51Z","timestamp":1764688491120},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[1992,9,1]],"date-time":"1992-09-01T00:00:00Z","timestamp":715305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Agents and Actions"],"published-print":{"date-parts":[[1992,9]]},"DOI":"10.1007\/bf01987895","type":"journal-article","created":{"date-parts":[[2005,8,4]],"date-time":"2005-08-04T02:08:24Z","timestamp":1123121304000},"page":"90-98","source":"Crossref","is-referenced-by-count":24,"title":["Antiarthritic profile of BF-389 \u2014 A novel anti-inflammatory agent with low ulcerogenic liability"],"prefix":"10.1007","volume":"37","author":[{"given":"S.","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"M. R.","family":"Frierson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Proch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. A.","family":"Miskowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. S.","family":"Rigby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. J.","family":"Schmolka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. W.","family":"Naismith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. C.","family":"Kreutzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Lindquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01987895_CR1","volume-title":"Anti-inflammatory and Anti-Rheumatic Drug","author":"K. D. Rainsford","year":"1985","unstructured":"K. D. Rainsford,Anti-inflammatory and Anti-Rheumatic Drug, Vol. 1 & II. CRC Press, Boca Raton, FL 1985."},{"key":"BF01987895_CR2","first-page":"165","volume-title":"Prostglandin Synthetase Inhibitors","author":"G. A. Higgs","year":"1974","unstructured":"G. A. Higgs, J. R. Vane, F. D. Hart and J. A. Wojtulewski,Effect of antiinflammatory drugs on prostaglandins in rheumatoid arthritis. InProstglandin Synthetase Inhibitors. (Eds. H. J. Robinson and J. R. Vane) pp. 165\u2013173. Raven Press, New York 1974."},{"key":"BF01987895_CR3","unstructured":"In:The Medical Letter on Drugs and Therapeutics, 33 (848) 1991."},{"key":"BF01987895_CR4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF01965633","volume":"20","author":"M. J. DiMartino","year":"1987","unstructured":"M. J. DiMartino, D. E. Griswold, B. A. Berkowitz, G. Poste and N. Hanna,Pharmacologic characterization of the antiinflammatory properties of a new dual inhibitor of lipoxygenase and cyclooxygenase. Agents and Actions20, 113\u2013123 (1987).","journal-title":"Agents and Actions"},{"key":"BF01987895_CR5","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/bmj.280.6219.964-a","volume":"1","author":"V. Wright","year":"1980","unstructured":"V. Wright and R. Amos,Do drugs change the course of rheumatoid arthritis. Br. Med. J.1, 964\u2013966 (1980).","journal-title":"Br. Med. J."},{"key":"BF01987895_CR6","first-page":"266","volume":"17","author":"P. Kuhl","year":"1985","unstructured":"P. Kuhl, H. O. Borbe, A. Romer, H. Fischer and M. J. Pharnham,Selective inhibition of leukotriene B4 formation by Ebselen: A novel approach to antiinflammatory therapy. Agents and Actions17, 266\u2013367 (1985).","journal-title":"Agents and Actions"},{"key":"BF01987895_CR7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF01977263","volume":"19","author":"M. A. Bray","year":"1986","unstructured":"M. A. Bray,Leukotrienes in inflammation. Agents and Actions19, 87\u201399 (1986).","journal-title":"Agents and Actions"},{"key":"BF01987895_CR8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/jop.1989.5.353","volume":"5","author":"M. S. Chang","year":"1989","unstructured":"M. S. Chang and G. C. Y. Chiou,Prevention of lens proteininduced ocular inflammation with cyclooxygenase and lipoxygenase inhibitors. J. Ocular Pharmacol.5, 353\u2013360 (1989).","journal-title":"J. Ocular Pharmacol."},{"key":"BF01987895_CR9","first-page":"305","volume":"28","author":"N. C. Barnes","year":"1989","unstructured":"N. C. Barnes, J. Evans, J. T. Zakrewski, P. J. Piper and J. F. Costello,Agents which inhibit leukotrienes and lipoxygenase. Agents and Actions28, 305\u2013312 (1989).","journal-title":"Agents and Actions"},{"key":"BF01987895_CR10","first-page":"107","volume":"XI","author":"J.-B. Montandon","year":"1989","unstructured":"J.-B. Montandon, et al.,In vitro versus in vivo activities of new 5-lipoxygenase inhibitors with anti-inflammatory activity. Int. J. Tissue React.XI, 107\u2013112 (1989).","journal-title":"Int. J. Tissue React."},{"key":"BF01987895_CR11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/030006059001800202","volume":"18","author":"R. J. Ancill","year":"1990","unstructured":"R. J. Ancill, Y. Rakahashi, Y. Kibune, R. Campbell and J. R. Smith,Randomized double-blind, placebo-controlled clinical trial of a selective 5-lipoxygenase inhibitor (AA-861) for the prevention of seasonal allergic rhinitis. J. Int. Med. Res.18, 75\u201388 (1990).","journal-title":"J. Int. Med. Res."},{"key":"BF01987895_CR12","first-page":"929","volume":"256","author":"G. W. Carter","year":"1991","unstructured":"G. W. Carter, et al.,5-lipoxygenase inhibitory activity of zileuton, J. Pharmacol. Exp. Ther.256, 929\u2013937 (1991).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF01987895_CR13","first-page":"409","volume-title":"Immunolpharmacology","author":"T. J. Rogers","year":"1989","unstructured":"T. J. Rogers,Immunopharmacology of regulatory cells. InImmunolpharmacology. (Eds. S. C. Gilman and T. J. Rogers) pp. 409\u2013463. Telford Press, Caldwell, NJ 1989."},{"key":"BF01987895_CR14","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/BF01966481","volume":"21","author":"H. Shirota","year":"1987","unstructured":"H. Shirota, K. Katayama, H. Ono, K. Chiba, S. Kobayashi, K. Terato, H. Ikuta and I. Yamatsu,Pharmacological properties of N-methoxy-3-(3,5-ditert-butyl-4-hyroxybenzylidene)-2-pyrrolidone (E5110) a novel nonsteroidal antiinflammatory agent. Agents and Actions21, 250\u2013252 (1987).","journal-title":"Agents and Actions"},{"key":"BF01987895_CR15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/art.1780340212","volume":"34","author":"W. D. Blackburn","year":"1991","unstructured":"W. D. Blackburn, L. W. Heck, L. D. Loose, J. D. Eskra and T. J. Carty.Inhibition of 5-Lipoxygenase product formation and polymorphonuclear cell degranulation by tenidap sodium in patients with rheumatoid arthritis. Arth. Rheum.34, 204\u2013210 (1991).","journal-title":"Arth. Rheum."},{"key":"BF01987895_CR16","first-page":"109","volume-title":"Nonsteroidal Antiinflammatory Drugs","author":"I. G. Otterness","year":"1985","unstructured":"I. G. Otterness and M. L. Bliven,Laboratory models for testing non-steroidal antiinflammatory drugs. InNonsteroidal Antiinflammatory Drugs. (Ed. J. G. Lombardino) Chap. 4, pp. 109\u2013252, Wiley, New York 1985."},{"key":"BF01987895_CR17","first-page":"127","volume":"185","author":"S. Wong","year":"1973","unstructured":"S. Wong, J. F. Gardocki and T. P. Pruss,Pharmacologic evaluation of Tolectin (tolmetin McN-2559) and McN2891, two anti-inflammatory agents. J. Pharmacol. Exp. Ther.185, 127\u2013138 (1973).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF01987895_CR18","volume-title":"Principles and Procedures of Statistics","author":"R. G. D. Steel","year":"1960","unstructured":"R. G. D. Steel and J. H. Torrie,Principles and Procedures of Statistics. McGraw-Hill, New York 1960."},{"key":"BF01987895_CR19","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-111-27849","volume":"111","author":"C. H. Winter","year":"1962","unstructured":"C. H. Winter, E. A. Risley and G. W. Nuss,Carrageenaninduced edema in the hind paw of the rat as an assay for antiinflammatory drugs. Proc. Soc. Exp. Biol. Med.111, 544\u2013547 (1962).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"BF01987895_CR20","first-page":"183","volume-title":"Pharmacometrics","author":"H. O. J. Collier","year":"1964","unstructured":"H. O. J. Collier,Analgesics in evaluation of drug activities. InPharmacometrics. (Eds. O. R. Laurence and A. L. Bacharach) pp. 183\u2013203, Academic Press, London 1964."},{"key":"BF01987895_CR21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1476-5381.1968.tb00973.x","volume":"32","author":"H. O. J. Collier","year":"1968","unstructured":"H. O. J. Collier, L. C. Dinneen, C. A. Johnson and C. Schneider,The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br. J. Pharmacol. Chemother.32, 295\u2013310 (1968).","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"BF01987895_CR22","first-page":"385","volume":"107","author":"Eddy","year":"1953","unstructured":"Eddy and Leimbach,Mouse hot plate test for narcotic analgesics. J. Pharmacol. Exp. Ther.107, 385 (1953).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF01987895_CR23","first-page":"625","volume":"226","author":"S. Wong","year":"1983","unstructured":"S. Wong and J. F. Gardocki,Antiinflammatory and antiarthritic evaluation of acetaminophen and its potentiation of tolmetin. J. Pharmacol. Exp. Ther.226, 625\u2013632 (1983).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF01987895_CR24","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4684-6265-4","volume-title":"The Dose-Response Relation in Pharmacology","author":"R. J. Tallarida","year":"1979","unstructured":"R. J. Tallarida and L. S. Jacob,The Dose-Response Relation in Pharmacology, Springer, New York 1979."},{"key":"BF01987895_CR25","volume-title":"Manual of Pharmacologic Calculations with Computer Program","author":"R. J. Tallarida","year":"1987","unstructured":"R. J. Tallarida and R. B. Murray,Manual of Pharmacologic Calculations with Computer Program, Second Edition, Springer, New York 1987.","edition":"Second Edition"},{"key":"BF01987895_CR26","first-page":"293","volume":"7","author":"S. Wong","year":"1984","unstructured":"S. Wong, C. Stearns and S. Desai,Separation of immunosuppressive from non-steroidal anti-inflammatory agents, using the adjuvant arthritis model, Adv. Inflamm. Res.7, 293 (1984).","journal-title":"Adv. Inflamm. Res."},{"key":"BF01987895_CR27","unstructured":"A. M., Bendele, K. J. Ruterbories, S. M. Spaethe, D. N. Benslay, T. D. Lindstrom, S. J. Lee and B. W. Naismith,Correlation of anti-inflammatory activity with peak tissue rather than peak plasma levels of BF-389. J. Pharmacol. Exp. Ther257. (1992)."},{"key":"BF01987895_CR28","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/BF01966502","volume":"21","author":"K. D. Rainsford","year":"1987","unstructured":"K. D. Rainsford,The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by non-steroidal antiinflammatory drugs in mice. Agents and Actions21, 316\u2013319 (1987).","journal-title":"Agents and Actions"},{"key":"BF01987895_CR29","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF01966503","volume":"21","author":"S. T. Nielsen","year":"1987","unstructured":"S. T. Nielsen, L. Beninati and J. Chang,REV 5901 and Ly 171,883 protect rat gastric mucosa against ethanol-induced damage, Agents and Actions21, 320\u2013322 (1987).","journal-title":"Agents and Actions"},{"key":"BF01987895_CR30","unstructured":"J. L. Wallace, D. W. Anderson, D. Argentieri and R. J. Capetola,Comparison of the Ulcerogenic properties of Tepoxalin with NSAIDs Abstract No. 198. Fifth International Conference of the Inflammation Research Association, Sept. 23\u201327, 1990. Laurel, White Haven, PA."},{"key":"BF01987895_CR31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF01972831","volume":"27","author":"D. J. Schrier","year":"1989","unstructured":"D. J. Schrier, M. Adamchak, A. M. Boctor, C. R. Kostlan, D. L. Flynn, J. H. Jordan Jr., M. E. Lesch and G. C. N. Okonkow,The in vivo antiinflammatory effects of (E)-2,6-bis (1,1-dimethyl-ethyl)-4-[4-(5-methyl-1H-pyrazol-3-yl) ethenul]phenol (PD127443) a novel dual inhibitor of 5-lipoxygenase and cyclooxygenase. Agents and Actions27, 391\u2013394 (1989).","journal-title":"Agents and Actions"},{"key":"BF01987895_CR32","first-page":"171","volume-title":"Newer Anti-Inflammatory Drugs \u2014 Anti-Inflammatory and Anti-Rheumatic Drugs","author":"A. C. Allison","year":"1985","unstructured":"A. C. Allison, W. H. Rooks II and E. J. Segre,Naproxen. InNewer Anti-Inflammatory Drugs \u2014 Anti-Inflammatory and Anti-Rheumatic Drugs, Vol II. (Ed. K. D. Rainsford) pp. 171\u2013188. CRC Press, Boca Raton, FL 1985."}],"container-title":["Agents and Actions"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01987895.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01987895\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01987895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T21:38:48Z","timestamp":1557783528000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01987895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,9]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1992,9]]}},"alternative-id":["BF01987895"],"URL":"https:\/\/doi.org\/10.1007\/bf01987895","relation":{},"ISSN":["0065-4299","1420-908X"],"issn-type":[{"value":"0065-4299","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,9]]}}}